These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8625445)
1. Apoptotic and anti-proliferative effects of fumonisin B1 in human keratinocytes, fibroblasts, esophageal epithelial cells and hepatoma cells. Tolleson WH; Melchior WB; Morris SM; McGarrity LJ; Domon OE; Muskhelishvili L; James SJ; Howard PC Carcinogenesis; 1996 Feb; 17(2):239-49. PubMed ID: 8625445 [TBL] [Abstract][Full Text] [Related]
2. The mycotoxin fumonisin induces apoptosis in cultured human cells and in livers and kidneys of rats. Tolleson WH; Dooley KL; Sheldon WG; Thurman JD; Bucci TJ; Howard PC Adv Exp Med Biol; 1996; 392():237-50. PubMed ID: 8850621 [TBL] [Abstract][Full Text] [Related]
3. Activation of mitogen-activated protein kinase by the carcinogenic mycotoxin fumonisin B1. Wattenberg EV; Badria FA; Shier WT Biochem Biophys Res Commun; 1996 Oct; 227(2):622-7. PubMed ID: 8878562 [TBL] [Abstract][Full Text] [Related]
4. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389 [TBL] [Abstract][Full Text] [Related]
5. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482 [TBL] [Abstract][Full Text] [Related]
6. Intravenous fumonisin B1 induces cell proliferation and apoptosis in the rat. Lim CW; Parker HM; Vesonder RF; Haschek WM Nat Toxins; 1996; 4(1):34-41. PubMed ID: 8680752 [TBL] [Abstract][Full Text] [Related]
7. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion. Tolleson WH; Couch LH; Melchior WB; Jenkins GR; Muskhelishvili M; Muskhelishvili L; McGarrity LJ; Domon O; Morris SM; Howard PC Int J Oncol; 1999 May; 14(5):833-43. PubMed ID: 10200332 [TBL] [Abstract][Full Text] [Related]
8. Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells. Shabalina IG; Panaretakis T; Bergstrand A; DePierre JW Carcinogenesis; 1999 Dec; 20(12):2237-46. PubMed ID: 10590214 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of fumonisin B1 on cell death in cultured cells: the significance of the elevated sphinganine. Yu CH; Lee YM; Yun YP; Yoo HS Arch Pharm Res; 2001 Apr; 24(2):136-43. PubMed ID: 11339633 [TBL] [Abstract][Full Text] [Related]
10. Compensatory regeneration as a mechanism for renal tubule carcinogenesis of fumonisin B1 in the F344/N/Nctr BR rat. Howard PC; Warbritton A; Voss KA; Lorentzen RJ; Thurman JD; Kovach RM; Bucci TJ Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):309-14. PubMed ID: 11359700 [TBL] [Abstract][Full Text] [Related]
11. Augmented fumonisin B1 toxicity in co-cultures: evidence for crosstalk between macrophages and non-parenchymatous liver epithelial cells involving proinflammatory cytokines. Sharma N; He Q; Sharma RP Toxicology; 2004 Oct; 203(1-3):239-51. PubMed ID: 15363598 [TBL] [Abstract][Full Text] [Related]
12. Fumonisin B1 influenced the effects of arachidonic acid, prostaglandins E2 and A2 on cell cycle progression, apoptosis induction, tyrosine- and CDC2-kinase activity in oesophageal cancer cells. Seegers JC; Joubert AM; Panzer A; Lottering ML; Jordan CA; Joubert F; Maree JL; Bianchi P; de Kock M; Gelderblom WC Prostaglandins Leukot Essent Fatty Acids; 2000 Feb; 62(2):75-84. PubMed ID: 10780872 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of fumonisin B1, diethylnitrosamine, and catechol on the SNO esophageal cancer cell line. Myburg RB; Dutton MF; Chuturgoon AA Environ Health Perspect; 2002 Aug; 110(8):813-5. PubMed ID: 12153764 [TBL] [Abstract][Full Text] [Related]
14. Ochratoxin A induces DNA damage and G2 phase arrest in human esophageal epithelium Het-1A cells in vitro. Liu J; Wu S; Shen H; Cui J; Wang Y; Xing L; Wang J; Yan X; Zhang X J Toxicol Sci; 2015; 40(5):657-65. PubMed ID: 26354382 [TBL] [Abstract][Full Text] [Related]
15. Fumonisin B1-induced hepatocellular and cholangiocellular tumors in male Fischer 344 rats: potentiating effects of 2-acetylaminofluorene on oval cell proliferation and neoplastic development in a discontinued feeding study. Lemmer ER; Vessey CJ; Gelderblom WC; Shephard EG; Van Schalkwyk DJ; Van Wijk RA; Marasas WF; Kirsch RE; Hall Pde L Carcinogenesis; 2004 Jul; 25(7):1257-64. PubMed ID: 14988222 [TBL] [Abstract][Full Text] [Related]
16. Effect of fumonisin B1 on phosphatidylethanolamine biosynthesis in Chinese hamster ovary cells. Badiani K; Byers DM; Cook HW; Ridgway ND Biochim Biophys Acta; 1996 Dec; 1304(3):190-6. PubMed ID: 8982265 [TBL] [Abstract][Full Text] [Related]
17. Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes. Marchetti M; Caliot E; Pringault E J Cell Sci; 2003 Apr; 116(Pt 8):1429-36. PubMed ID: 12640028 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): a model for reducing fumonisin-induced nephrotoxicity in vivo. He Q; Riley RT; Sharma RP Pharmacol Toxicol; 2002 May; 90(5):268-77. PubMed ID: 12076308 [TBL] [Abstract][Full Text] [Related]
19. Analysis of fumonisin B1-induced apoptosis. Jones C; Ciacci-Zanella JR; Zhang Y; Henderson G; Dickman M Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):315-20. PubMed ID: 11359701 [TBL] [Abstract][Full Text] [Related]
20. Tissue sphinganine as a biomarker of fumonisin-induced apoptosis. Delongchamp RR; Young JF Food Addit Contam; 2001 Mar; 18(3):255-61. PubMed ID: 11304034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]